Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Q1 2026 Trading Update

21 Apr 2026 07:00

RNS Number : 2073B
Norman Broadbent PLC
21 April 2026
 

 

Norman Broadbent plc

("Norman Broadbent")

 

Q1 2026 TRADING UPDATE

 

Solid performance, investment in growth and FY26 expectations reiterated

 

Norman Broadbent (AIM: NBB), a leading Executive Search and Interim Management firm, announces a trading update for the first quarter ended 31 March 2026 ("Q1").

 

Headlines

 

· NFI of £2.2m for Q1 26 (Q1 25: £3.0m), reflects a solid trading performance against a strong comparative period in 2025

· Secured four net new fee earners through organic recruitment, consistent with the objective to invest in growth by increasing fee-earning capacity

· Completed the acquisition of Society Limited in February 2026, adding five additional full-time staff and broadening the Group's platform capability

 

Kevin Davidson, CEO of Norman Broadbent, said:

"We started 2026 on the back of a record 2025 and with Q4 our strongest quarter in over a decade. Q4 was bolstered by a very strong end to the year with a material element of NFI we anticipated securing in January 2026 pulled forward into December 2025. The monthly run-rate during Q1 markedly improved after January. Together with our current visibility, this encouraging performance underpins our confidence in a further year of NFI growth in FY26, in line with our expectations. We remain of the view that progress this year from one quarter to the next is likely to be non-linear and we obviously continue to monitor events in the Middle East carefully.

 

Our strategic goals for 2026 are clear: investing in headcount growth and developing the team to drive our fee-earner capacity; exploring options to accelerate growth through M&A where it makes strategic and financial sense to do so; and remaining laser focused on short term performance, exceptional client delivery and leveraging our winning culture. The Society acquisition in the quarter is consistent with our disciplined approach and complements our organic recruitment in the quarter as we add capability, sector depth and diversification. We are making good progress in building a stronger business and with our track record of navigating uncertainty we expect to make continued progress in the year and years ahead."

 

Contacts: 

 

Norman Broadbent plc 

Via Gracechurch Group

Kevin Davidson, CEO 

Mehr Malik, CFO

Cavendish Capital Markets Limited (Nominated Adviser and Broker)  

+44 (0)20 7220 0500

Julian Blunt, Seamus Fricker, Andrea Callaghan - Corporate Finance

Jasper Berry, Matt Lewis - Sales / Corporate Broking 

Gracechurch Group (Financial Media & Investor Relations )

+44 (0)20 4582 3500

Murdo Montgomery

normanbroadbent@gracechurchpr.com

Tommy Bryson

Anysia Virdi

  

About Norman Broadbent:

 

Norman Broadbent (AIM: NBB) is a professional services firm focused on executive search, senior interim management solutions and bespoke leadership advisory services working across the UK and internationally.

 ​ 

Established as the first UK-headquartered search firm in 1979, the firm has a 40+ year track record of shaping leadership across industries including Consumer, Financial Services, Industrials, Life Sciences, Investor and TMT.

 

www.normanbroadbent.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAKKBKCBKDKQB
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.